Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jun;34(6):864-8.
doi: 10.1002/humu.22314. Epub 2013 Apr 12.

Deficiency of the cyclin-dependent kinase inhibitor, CDKN1B, results in overgrowth and neurodevelopmental delay

Affiliations
Free PMC article
Case Reports

Deficiency of the cyclin-dependent kinase inhibitor, CDKN1B, results in overgrowth and neurodevelopmental delay

William Grey et al. Hum Mutat. 2013 Jun.
Free PMC article

Abstract

Germline mutations in the cyclin-dependent kinase inhibitor, CDKN1B, have been described in patients with multiple endocrine neoplasia (MEN), a cancer predisposition syndrome with adult onset neoplasia and no additional phenotypes. Here, we describe the first human case of CDKN1B deficiency, which recapitulates features of the murine CDKN1B knockout mouse model, including gigantism and neurodevelopmental defects. Decreased mRNA and protein expression of CDKN1B were confirmed in the proband's peripheral blood, which is not seen in MEN syndrome patients. We ascribed the decreased protein level to a maternally derived deletion on chromosome 12p13 encompassing the CDKN1B locus (which reduced mRNA expression) and a de novo allelic variant (c.-73G>A) in the CDKN1B promoter (which reduced protein translation). We propose a recessive model where decreased dosage of CDKN1B during development in humans results in a neuronal phenotype akin to that described in mice, placing CDKN1B as a candidate gene involved in developmental delay.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A: Pedigree of the nonconsanguineous Bengali family. The proband (II:1) presented with overgrowth, autism, and severe developmental delay with absent speech at the age of 3 years. Array CGH demonstrated a deletion on 12p13.1 in the proband and his mother (I:2). Sanger sequencing of the CDKN1B gene demonstrated a SNP, rs34330: −79C>T, in the proband's father (I:1) and his sister (II:2). The proband harbors a de novo variant that is not seen in other members of the family at c.−73G>A. B: Array CGH analysis. Diagrammatic depiction of the maternally derived 12p13.1 deletion identified by array CGH (Agilent AMAID 017457). Coordinates displayed in build NCBI36/hg18. The position of probes showing normal copy number is shown in green, probes showing abnormal copy number are shown in red. Probe names, base-pair coordinates, and fluorescent ratios for the abnormal probes are shown (bottom right). For a patient: reference ratio of 1:2 (one allele deleted in the patient), the theoretical log2 value is −1. C: rs34330:C>T and c.−73G>A. Bidirectional Sanger sequencing of the promoter region of CDKN1B revealed the rs34330:C>T (−79C>T) in the proband's father and sister (I:1, II:2) (representative sequencing trace shown). In the reference sequence, the ancestral allele of T is shown but variant at this site is common in human populations (Supp. Fig. S3). The T allele has been linked to cancer [Chang, ; Landa et al., 2010]. A previously unreported SNP c.−73G>A was seen in the proband only (II:1). Sequencing primers are detailed in Supp. Figure S4A.
Figure 2
Figure 2
A: Quantification of CDKN1B mRNA expression by qPCR. Total RNA was extracted from peripheral blood. White blood cells from peripheral blood were spun down, lysed, and total RNA was purified using the Qiagen RNA easy extraction kit (cat. 52304). RNA was reversed transcribed, and quantitative PCR was carried using the Qiagen one-step SYBR green RT-PCR kit. Q-PCR primers (primer sequences are detailed in Supp. Fig. S4B) spanned the 3′ end of exon 1 (forward) of CDKN1B to the 5′ end of exon 2 (reverse). The amount of CDKN1B detected was normalized against the ubiquitously expressed ABL1 gene and expressed as a relative value Ratio (ABL1/CDKN1B) = 2CT(ABL1)-CT(CDKN1B). B: Quantification of CDKN1B minimal promoter activity. Region incorporating the 5′UTR of CDKN1B (encompassing the −79 and −73 residues) were amplified from patient DNA and subcloned into the pGL3 basic luciferase reporter vector (Promega cat. E1751). One microgram of pGL3−79C-73G, pGL3−79T-79G, pGL3−79C-73A, or an empty pGL3 vector was cotransfected with 20 ng of pRL-TK (Renilla reporter construct, Promega cat. E2241) into HEK293T cells with the ProFection mammalian transfection system (Promega cat. E1200) according to the manufacturer's protocol. Cells were transfected for 48 hr, followed by a 12 hr period of serum starvation. The dual-luciferase reporter assay system (Promega cat. E1910) was used to assay relative luciferase activity. The data represent the mean of three independent experiments with standard error bars. C: Western blot analysis of CDKN1B from white blood cells. Protein samples were extracted from peripheral blood samples by first isolating white blood cells through centrifugation. These cells were subsequently lysed using RIPA lysis buffer (50 mM Tris HCl pH 7.4, 1% NP40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA) and run on a 12% SDS-PAGE. Western blotting was carried out using an anti-p27 antibody (BD Biosciences cat. 610242) and an anti-β-tubulin antibody (Cell Signaling cat. 2128) (left). Relative intensity of the signal obtained from the western blot was quantified using ImageJ (NIH). Bar chart shows the average of signals (and standard error) quantified from three blots normalized to β-tubulin level in each independent blood sample (right).

Similar articles

Cited by

References

    1. Chang Bl. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer. Cancer Res. 2004;64(6):1997–1999. - PubMed
    1. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai L, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1 deficient mice. Cell. 1996;85:733–744. - PubMed
    1. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M, Lee H, Shih WJ, Cardiff RD, Shen MM, Abate-Shen C. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA. 2004;101(49):17204–17209. - PMC - PubMed
    1. Goto T, Mitsuhashi T, Takahashi T. Altered patterns of neuron production in the p27 knockout mouse. Dev Neurosci. 2004;26(2–4):208–217. - PubMed
    1. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A. Enhanced growth of mice lacking the cyclin dependent kinase inhibitor function of p27Kip1. Cell. 1996;85:721–732. - PubMed

Publication types

Substances